ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

Cervical Cancer Vaccine More Active In Teen Girls

February 24, 2006

Fewer Side Effects With IMRT Than Traditional Radiation

August 31, 2007

Oncology Unit – How To Plan, Start It

February 10, 1978

FDA Approves Genetic Test For Breast Cancer Patients

January 25, 2008

Program Announcements n Animal Retroviruses, Other Topics, Approved

March 30, 1990

Funding Opportunities.

March 22, 2002